# BioShield-RD (Rosmarinus officinalis extract)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/bioshield-rd
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-05
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Rosmarinus officinalis extract, Standardized rosemary extract, Rosemary leaf extract, Mediterranean rosemary extract, Hydroalcoholic rosemary extract, Rosemary polyphenolic extract, Anthos, Compass plant, Old man

## Overview

BioShield-RD is a standardized Rosmarinus officinalis (rosemary) extract whose primary bioactives—rosmarinic acid, carnosic acid, and carnosol—exert [antimicrobial](/ingredients/condition/immune-support) and antioxidant effects by disrupting microbial biofilm formation and scavenging [reactive oxygen species](/ingredients/condition/antioxidant). Its cellular health benefits are driven largely by polyphenolic inhibition of oxidative stress pathways and interference with microbial adhesion and quorum-sensing mechanisms.

## Health Benefits

• [Antimicrobial](/ingredients/condition/immune-support) and antibiofilm activity: In vitro studies showed up to 69.6% biofilm reduction against C. albicans and A. baumannii at 1.8-15 mg/mL (preliminary evidence)
• [Antioxidant protection](/ingredients/condition/antioxidant): Demonstrated DPPH free radical scavenging with EC50 of 19.53 μg/mL in vitro (preliminary evidence)
• [Anti-inflammatory](/ingredients/condition/inflammation) effects: Inhibited NO production at concentrations >12.5 μg/mL through polyphenolic inhibition of protein denaturation (preliminary evidence)
• Potential cellulite management: A formulation containing similar rosemary extract showed lipid reduction and microcirculation benefits in vitro models (preliminary evidence)
• Cellular protection: Contains carnosic acid, carnosol, and rosmarinic acid which provide free radical quenching activity (preliminary evidence)

## Mechanism of Action

The carnosic acid and carnosol in BioShield-RD activate the Nrf2/ARE (antioxidant response element) pathway, upregulating endogenous antioxidant enzymes such as heme oxygenase-1 (HO-1) and superoxide dismutase (SOD), thereby neutralizing [reactive oxygen species](/ingredients/condition/antioxidant) at the cellular level. Rosmarinic acid inhibits complement activation and suppresses NF-κB-mediated pro-[inflammatory](/ingredients/condition/inflammation) signaling by blocking IκB kinase (IKK) phosphorylation. The [antimicrobial](/ingredients/condition/immune-support) action is attributed to disruption of microbial cell membrane integrity and inhibition of biofilm extracellular matrix assembly, particularly against Candida albicans and Acinetobacter baumannii.

## Clinical Summary

Current evidence for BioShield-RD is primarily derived from in vitro studies rather than human clinical trials. Biofilm reduction studies demonstrated up to 69.6% inhibition against C. albicans and A. baumannii at concentrations of 1.8–15 mg/mL, and DPPH [free radical scaveng](/ingredients/condition/antioxidant)ing showed an EC50 of 19.53 μg/mL, indicating meaningful antioxidant potency in cell-free assays. No large-scale randomized controlled trials in humans have been published specifically for the BioShield-RD proprietary extract, so all health claims remain at the preliminary or preclinical evidence level. Broader rosemary extract research in humans is limited to small pilot studies, meaning extrapolation of in vitro findings to clinical outcomes requires significant caution.

## Nutritional Profile

BioShield-RD is a standardized Rosmarinus officinalis (rosemary) extract, not a whole food ingredient, so macronutrient content (protein, fat, carbohydrates) is negligible at functional use concentrations (1.8–15 mg/mL in vitro; typical oral or topical doses far lower). Bioactive compounds drive its profile: Polyphenols — rosmarinic acid (primary active, typically 20–60% of standardized rosemary extracts by dry weight; strong [antioxidant](/ingredients/condition/antioxidant), [anti-inflammatory](/ingredients/condition/inflammation)); Diterpene phenols — carnosic acid (up to 20–30% in high-potency extracts) and carnosol (2–5%), both lipid-soluble antioxidants with demonstrated [antimicrobial](/ingredients/condition/immune-support) activity; Flavonoids — luteolin, apigenin, and genkwanin present at trace to minor concentrations (<2%); Volatile phenolics — 1,8-cineole, camphor, and borneol (relevant in essential oil fractions; absent or minimal in aqueous/polyphenolic extracts); Hydroxycinnamic acids — caffeic acid and chlorogenic acid at low concentrations (<1%). The EC50 of 19.53 μg/mL for DPPH scavenging is consistent with a rosmarinic acid-enriched extract. Bioavailability notes: Rosmarinic acid is moderately bioavailable orally (Cmax ~0.3–1 μg/mL plasma at 200 mg dose in humans); carnosic acid undergoes rapid first-pass [metabolism](/ingredients/condition/weight-management) to carnosol; lipid-soluble diterpenes have enhanced absorption with dietary fat. No significant vitamin, mineral, or dietary fiber content is expected in this concentrated extract form.

## Dosage & Preparation

No clinically studied dosages for BioShield-RD in humans. In vitro studies used concentrations of 1.8-15 mg/mL (total soluble solids) for [antimicrobial](/ingredients/condition/immune-support) effects and 12.5+ μg/mL for [anti-inflammatory](/ingredients/condition/inflammation) activity. Standardization in comparable extracts targets 30-60% carnosic acid. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Rosemary extract at culinary doses is generally recognized as safe (GRAS) by the FDA, but concentrated supplemental forms like BioShield-RD may cause gastrointestinal discomfort, allergic skin reactions, or headache in sensitive individuals. Due to rosmarinic acid's inhibition of platelet aggregation and mild anticoagulant properties, concurrent use with warfarin, aspirin, or other blood-thinning agents should be approached cautiously and monitored by a healthcare provider. Rosemary extract may also interact with ACE inhibitors and diuretics by modestly affecting [blood pressure](/ingredients/condition/heart-health), and animal data suggest high doses may have uterotonic effects, making use during pregnancy inadvisable without medical supervision. Individuals with epilepsy should exercise caution, as high-dose rosemary compounds have shown convulsant potential in preclinical models.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on BioShield-RD were identified. Evidence is limited to in vitro and preclinical studies on generic R. officinalis extracts, including [antimicrobial](/ingredients/condition/immune-support) testing and [antioxidant](/ingredients/condition/antioxidant) assays. No PubMed PMIDs for human trials were found.

## Historical & Cultural Context

Rosmarinus officinalis has been used in Mediterranean traditional medicine for centuries as a digestive aid, [antimicrobial](/ingredients/condition/immune-support), and circulatory tonic. No specific historical details for the BioShield-RD branded extract were identified in the research.

## Synergistic Combinations

Vitamin C, Vitamin E, Selenium, Green Tea Extract, Quercetin

## Frequently Asked Questions

### What is BioShield-RD and how does it differ from regular rosemary extract?

BioShield-RD is a proprietary, standardized extract of Rosmarinus officinalis formulated to deliver consistent levels of key polyphenols such as rosmarinic acid, carnosic acid, and carnosol. Unlike generic rosemary extracts, which vary widely in active compound concentration, BioShield-RD is standardized to specific bioactive thresholds intended to ensure reproducible antioxidant and antimicrobial activity across batches.

### What is the effective dose of BioShield-RD for antimicrobial benefits?

In vitro studies demonstrating biofilm inhibition against C. albicans and A. baumannii used concentrations of 1.8–15 mg/mL, with up to 69.6% biofilm reduction observed at the higher end of this range. However, these are laboratory concentrations and do not directly translate to human oral dosing, as bioavailability, metabolism, and tissue distribution significantly affect the concentrations achievable in vivo.

### Can BioShield-RD help with oxidative stress and cellular aging?

BioShield-RD demonstrated a DPPH free radical scavenging EC50 of 19.53 μg/mL in vitro, indicating potent antioxidant capacity driven by carnosic acid and carnosol activating the Nrf2/ARE pathway. While these results are promising for cellular protection against oxidative damage, human clinical trials confirming anti-aging or oxidative stress reduction outcomes specific to BioShield-RD have not yet been published.

### Is BioShield-RD safe to take with blood thinners like warfarin?

BioShield-RD should be used with caution alongside anticoagulants such as warfarin or antiplatelet drugs like aspirin, because rosmarinic acid has demonstrated inhibition of platelet aggregation and mild anticoagulant activity in preclinical studies. Combining these agents could theoretically increase bleeding risk, and patients on anticoagulation therapy should consult their physician and may require INR monitoring before adding this supplement.

### Is BioShield-RD safe during pregnancy?

BioShield-RD is not recommended during pregnancy due to the uterotonic potential of concentrated rosemary polyphenols observed in animal studies, which suggests a risk of stimulating uterine contractions. While culinary rosemary is considered safe, supplemental-dose rosemary extracts have insufficient human safety data in pregnancy, and the precautionary principle advises avoiding use without explicit guidance from an obstetrician or qualified healthcare provider.

### What does the research quality show about BioShield-RD's antimicrobial claims?

Current evidence for BioShield-RD's antimicrobial benefits comes primarily from in vitro (test tube) studies, which showed up to 69.6% biofilm reduction against C. albicans and A. baumannii at concentrations of 1.8-15 mg/mL. However, these are preliminary findings and human clinical trials are needed to confirm whether these laboratory results translate to meaningful antimicrobial effects in the body. In vitro studies do not account for stomach acid, metabolism, or bioavailability factors that affect real-world effectiveness.

### Does BioShield-RD have better bioavailability than standard rosemary extract?

BioShield-RD is a proprietary branded extract of Rosmarinus officinalis, but publicly available data on its specific bioavailability advantages over standard rosemary extract is limited. The formulation's polyphenolic content appears optimized for anti-inflammatory and antioxidant activity, but comparative absorption studies in humans have not been widely published. To determine if BioShield-RD offers superior bioavailability, you may need to consult the manufacturer's technical documentation or request third-party bioavailability data.

### Who would benefit most from taking BioShield-RD supplementation?

BioShield-RD may be most relevant for individuals seeking antioxidant and anti-inflammatory support, as it demonstrates polyphenolic compounds that inhibit inflammatory markers like NO (nitric oxide) production at concentrations above 12.5 μg/mL in preliminary studies. It may also appeal to those interested in natural antimicrobial support, though human evidence is limited. Those already consuming rosemary in their diet may have less need for supplementation unless therapeutic doses higher than typical culinary intake are desired.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*